Acute lung injury (ALI) affects over 10% of patients hospitalised in critical care, with acute
respiratory distress syndrome (ARDS) being the most severe form of ALI and having a …

Acute respiratory distress syndrome (ARDS) is a heterogeneous cause of respiratory failure
that has a rapid onset, a high mortality rate, and for which there is no effective …

Acute respiratory distress syndrome (ARDS) is a clinical syndrome associated with
oxygenation failure resulting from a direct pulmonary or indirect systemic insult. It is a …

Acute respiratory distress syndrome (ARDS), characterized clinically by hypoxemia and
bilateral chest infiltrates in the absence of elevated hydrostatic pressures, is a disease …

It is generally accepted that neutrophils play a key role in the development of acute
respiratory distress syndrome (ARDS)(1). Chemotactic mediators cause an accumulation of …

Introduction Treatments for the acute respiratory distress syndrome (ARDS) are mainly
supportive, and ventilatory management represents a key approach in these patients …

Objective: The objective of this study was to review known clinical predictors and biologic
markers of adverse clinical outcomes in acute lung injury (ALI) and acute respiratory distress …

Acute respiratory distress syndrome (ARDS) is a frequently encountered clinical syndrome
associated with unacceptably high morbidity and mortality. 1 Since its first description in …

The pathogenesis of the acute respiratory distress syndrome (ARDS) remains incompletely
understood. It is generally believed that extrapulmonary factors, such as sepsis and trauma …

The acute respiratory distress syndrome (ARDS) causes 40% mortality in approximately
200,000 critically ill patients annually in the United States. ARDS is caused by protein-rich …